EVD:XETRCTS Eventim AG & Co. KGaA Analysis
Data as of 2026-06-13 - not real-time
€50.90
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
CTS Eventim delivered a double‑digit increase in first‑quarter revenue and earnings, driven by a resilient ticketing platform and a growing live‑entertainment and venue business. The company posted a healthy adjusted EBITDA margin close to the high‑teens, reinforcing its operational efficiency. A dividend yield near three percent, coupled with a payout ratio just above fifty percent, suggests that the current payout is well‑backed by cash flow. The market price sits slightly above the discounted‑cash‑flow fair‑value estimate, implying limited upside on a pure valuation basis. Technical signals are mixed: the RSI is below forty, hinting at oversold conditions, while the MACD remains in a bearish configuration and the 20‑day SMA sits just above the 50‑day SMA, confirming a short‑term downtrend. Volume has been tapering, and the stock is trading close to its identified support level.
Despite the bearish technical backdrop, the fundamentals remain robust. Revenue growth of over twenty percent year‑over‑year, expanding margins, and a solid balance sheet with ample cash and modest debt provide a strong foundation. The company’s exposure across multiple European markets and the United States diversifies geographic risk. Analyst consensus remains bullish, with a “buy” recommendation and target prices substantially higher than the current level, indicating confidence in longer‑term upside. Overall, the stock appears positioned for a potential rebound as earnings momentum continues and technical pressures ease.
Despite the bearish technical backdrop, the fundamentals remain robust. Revenue growth of over twenty percent year‑over‑year, expanding margins, and a solid balance sheet with ample cash and modest debt provide a strong foundation. The company’s exposure across multiple European markets and the United States diversifies geographic risk. Analyst consensus remains bullish, with a “buy” recommendation and target prices substantially higher than the current level, indicating confidence in longer‑term upside. Overall, the stock appears positioned for a potential rebound as earnings momentum continues and technical pressures ease.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Technical bearish trend with MACD below signal
- Price near identified support level
- Strong Q1 earnings providing a cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustained double‑digit revenue growth
- Attractive dividend yield and payout sustainability
- Analyst consensus and target price upside
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Expanding live‑entertainment and venue footprint
- Robust cash generation and low leverage
- Diversified geographic exposure across Europe and the US
Key Metrics & Analysis
Financial Health
Revenue Growth23.00%
Profit Margin9.23%
P/E Ratio16.6
ROE25.45%
ROA7.38%
Debt/Equity9.56
P/B Ratio4.3
Op. Cash Flow€332.6M
Free Cash Flow€104.1M
Industry P/E17.0
Technical Analysis
TrendBearish
RSI37.0
Support€49.44
Resistance€63.00
MA 20€55.63
MA 50€55.76
MA 200€70.78
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Fair Value€49.81
Target Price€88.63
Upside/Downside74.12%
GradeFair
TypeBlend
Dividend Yield2.83%
Risk Assessment
Beta0.71
Volatility38.78%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.